Clinical Trial Update: Finding New Targets by Proteomic Approaches (InnovRT1)

View source ↗

Summary

This clinical trial update reports a completed study (InnovRT1) investigating proteomic approaches to identify new targets for atypical teratoid/rhabdoid tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: ATRT | Status: COMPLETED